These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31836255)

  • 1. Human papillomavirus vaccination coverage, policies, and practical implementation across Europe.
    Nguyen-Huu NH; Thilly N; Derrough T; Sdona E; Claudot F; Pulcini C; Agrinier N;
    Vaccine; 2020 Feb; 38(6):1315-1331. PubMed ID: 31836255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018-2019).
    Bonanni P; Faivre P; Lopalco PL; Joura EA; Bergroth T; Varga S; Gemayel N; Drury R
    Expert Rev Vaccines; 2020 Nov; 19(11):1073-1083. PubMed ID: 33267673
    [No Abstract]   [Full Text] [Related]  

  • 3. Exploring variation in human papillomavirus vaccination uptake in Switzerland: a multilevel spatial analysis of a national vaccination coverage survey.
    Riesen M; Konstantinoudis G; Lang P; Low N; Hatz C; Maeusezahl M; Spaar A; Bühlmann M; Spycher BD; Althaus CL
    BMJ Open; 2018 May; 8(5):e021006. PubMed ID: 29773702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
    Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
    Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic literature review of human papillomavirus vaccination strategies in delivery systems within national and regional immunization programs.
    Felsher M; Shumet M; Velicu C; Chen YT; Nowicka K; Marzec M; Skowronek G; Pieniążek I
    Hum Vaccin Immunother; 2024 Dec; 20(1):2319426. PubMed ID: 38410931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
    Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
    S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide.
    Owsianka B; Gańczak M
    Przegl Epidemiol; 2015; 69(1):53-8, 151-5. PubMed ID: 25862448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful implementation and results of an HPV vaccination program in Geneva Canton, Switzerland.
    Jeannot E; Petignat P; Sudre P
    Public Health Rep; 2015; 130(3):202-6. PubMed ID: 25931623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus vaccination coverage in Luxembourg - Implications of lowering and restricting target age groups.
    Latsuzbaia A; Arbyn M; Weyers S; Mossong J
    Vaccine; 2018 Apr; 36(18):2411-2416. PubMed ID: 29602702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strengthening the Effectiveness of National, State, and Local Efforts to Improve HPV Vaccination Coverage in the United States: Recommendations From the National Vaccine Advisory Committee.
    Approved by the National Vaccine Advisory Committee on June 25, 2018
    Public Health Rep; 2018; 133(5):543-550. PubMed ID: 30091942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Policy and socio-cultural differences between cantons in Switzerland with high and low adolescent vaccination coverage for hepatitis B and HPV.
    Masserey Spicher V; Weiss MG
    Vaccine; 2019 Dec; 37(52):7539-7546. PubMed ID: 31630937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus (HPV) vaccination coverage among French adolescents: A claims data study.
    de Pouvourville G; Guyot E; Farge G; Belhassen M; Bérard M; Jacoud F; Bensimon L; Baldauf JJ
    Vaccine; 2024 Sep; 42(22):126039. PubMed ID: 38852035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccination acceptance and hesitancy in South Africa: Research and policy agenda.
    Ngcobo NJ; Burnett RJ; Cooper S; Wiysonge CS
    S Afr Med J; 2018 Dec; 109(1):13-15. PubMed ID: 30606297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social determinants of community-level human papillomavirus vaccination coverage in aschool-based vaccination programme.
    Jean S; Elshafei M; Buttenheim A
    Sex Transm Infect; 2018 Jun; 94(4):248-253. PubMed ID: 29330310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus vaccine introduction--the first five years.
    Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
    Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of HPV vaccines in the age of nonavalent vaccination.
    Quattrone F; Canale A; Filippetti E; Tulipani A; Porretta A; Lopalco PL
    Minerva Pediatr; 2018 Feb; 70(1):59-66. PubMed ID: 29363293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parental attitudes towards male human papillomavirus vaccination: a pan-European cross-sectional survey.
    Lee Mortensen G; Adam M; Idtaleb L
    BMC Public Health; 2015 Jul; 15():624. PubMed ID: 26152138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program.
    Faisal-Cury A; Levy RB; Tourinho MF; Grangeiro A; Eluf-Neto J
    BMC Public Health; 2020 Apr; 20(1):458. PubMed ID: 32252705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.